Skip to content

Clinical trials

Urinary Bladder, Overactive trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Overactive Country / region: South Korea Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20063
20076
20082
20097
20104
20114
20123
20132
20144
20154
20163
20173
20184
20192
20203
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53
Unknown status7
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer8
Samsung Medical Center8
Seoul National University Hospital7
Astellas Pharma Europe B.V.4
Astellas Pharma Inc4
KYU-SUNG LEE4
Astellas Pharma Singapore Pte. Ltd.3
Jeil Pharmaceutical Co., Ltd.3
Allergan2
Asan Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Overactive62
Urinary Incontinence7
Prostatic Hyperplasia5
Nocturia2
Urinary Bladder, Neurogenic2
Hyperthermia1
Lower Urinary Tract Symptoms1
Mycoplasma Infections1
Parkinson Disease1
Spinal Dysraphism1

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.